1331 - 1340 of 8823 Results
Title
Year
-
RESTRICTEDTitle: Therapeutic approaches to cholinergic deficiency in Lewy body diseasesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 1Start Page: 41End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1676152Citation Count: 11
-
OPENTitle: Clinical Chronobiology: Circadian Rhythms in Health and DiseaseJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 45Issue #: 03Start Page: 317End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1055/a-2538-3259Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12323393Citation Count: 2
-
OPENTitle: Targeting the proteostasis network in Huntington’s diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 49Issue #:Start Page: 92End Page: 103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.arr.2018.11.006Best OA location URL: https://doi.org/10.1016/j.arr.2018.11.006Citation Count: 78
-
OPENTitle: A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 11Start Page: 8129End Page: 8152Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14250Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14250Citation Count: 12
-
OPENTitle: Adapting the proteostasis capacity to sustain brain healthspanJournal Name: CellPublisher: Elsevier BVVol: 184Issue #: 6Start Page: 1545End Page: 1560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2021.02.007Best OA location URL: http://www.cell.com/article/S0092867421001574/pdfCitation Count: 108
-
RESTRICTEDTitle: Volitional Control of Brain Motor Activity and Its Therapeutic PotentialJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 8Start Page: 1187End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.007Citation Count: 14
-
OPENTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 68
-
OPENTitle: Body-first Parkinson’s disease and variant Creutzfeldt–Jakob disease – similar or different?Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 164Issue #:Start Page: 105625End Page: 105625Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105625Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105625Citation Count: 7
-
OPENTitle: Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and managementJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 547End Page: 555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000000955Best OA location URL: https://hal.science/hal-03298526Citation Count: 19
-
OPENTitle: Higher Frequency of Certain Cancers inLRRK2G2019S Mutation Carriers With Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 1Start Page: 58End Page: 58Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1973Best OA location URL: http://doi.org/10.1001/jamaneurol.2014.1973Citation Count: 91